Advertisement
Screener

AXSOME THERAPEUTICS, INC. (AXSM) Graph

AXSM Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $218.38M; Cost of revenue (m); Research and development $46.23M; Selling, general and administrative $208.14M.
  • 2026-03-31: Revenue $191.20M; Cost of revenue (m); Research and development $52.68M; Selling, general and administrative $185.00M.
  • 2025-12-31: Revenue $196.00M*; Cost of revenue (m); Research and development $48.79M*; Selling, general and administrative $169.30M*.
  • 2025-09-30: Revenue $170.99M; Cost of revenue (m); Research and development $40.16M; Selling, general and administrative $150.24M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

AXSM revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Royalty AndMilestone Revenue$2.02MProduct$216.36MRevenue$218.38MOperating income-$49.65MResearch & development$46.23MSelling, general& administrative$208.14MPre-tax income-$51.19MNet income-$51.31M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$218.38M(m)$46.23M$208.14M(m)$128.00K-$51.31M
2026-03-31$191.20M(m)$52.68M$185.00M(m)$0.00-$64.54M
2025-12-31$196.00M*(m)$48.79M*$169.30M*(m)$430.00K*-$28.56M*
2025-09-30$170.99M(m)$40.16M$150.24M(m)$0.00-$47.23M
2025-06-30$150.04M(m)$49.54M$130.28M(m)-$960.00K-$47.97M
2025-03-31$121.46M(m)$44.78M$120.79M(m)$0.00-$59.41M
2024-09-30$104.76M(m)$45.39M$95.56M(m)$0.00-$64.60M
2024-06-30$87.17M(m)$49.85M$103.55M(m)$0.00-$79.34M
2024-03-31$75.00M(m)$36.83M$98.97M(m)$0.00-$68.36M
2023-09-30$57.79M(m)$28.77M$83.19M(m)-$678.00K-$62.20M
2023-06-30$46.70M(m)$20.58M$78.94M(m)-$617.00K-$67.17M
2023-03-31$94.58M(m)$17.79M$74.19M(m)$2.58M-$11.22M
2022-12-31(m)$2.30M*(m)(m)(m)$0.00*(m)
2022-09-30$16.85M$1.90M$14.88M$40.89M(m)(m)-$44.82M
2022-06-30$8.82M$1.00M$15.79M$31.16M(m)(m)-$41.44M
2022-03-31(m)(m)$12.59M$25.70M$38.29M$0.00-$39.63M
2021-12-31(m)(m)(m)(m)$32.61M*(m)(m)
2021-09-30$0.00(m)$13.18M$20.23M$33.41M(m)-$34.88M
2021-06-30$0.00$1.00M$14.50M$16.34M$30.85M(m)-$32.28M
2021-03-31(m)(m)$16.60M(m)$27.84M$0.00-$29.26M
2020-12-31(m)(m)(m)(m)$27.74M(m)-$29.16M
2020-09-30(m)(m)$14.80M(m)$21.13M(m)-$22.92M
2020-06-30(m)(m)$10.54M(m)$17.78M(m)-$18.33M
2020-03-31(m)(m)$27.52M(m)$32.49M$0.00-$32.48M
2019-12-31(m)(m)(m)(m)$24.43M(m)-$24.81M
2019-09-30(m)(m)$15.84M(m)$18.95M(m)-$19.14M
2019-06-30(m)(m)$11.00M(m)$13.45M(m)-$13.76M
2019-03-31(m)(m)$7.60M(m)$10.42M(m)-$10.64M
2018-12-31(m)(m)(m)(m)$9.45M(m)-$9.60M
2018-09-30(m)(m)$6.04M(m)$8.24M-$217.42K-$8.28M
2018-06-30(m)(m)$5.55M(m)$7.99M(m)-$8.28M
2018-03-31(m)(m)$4.75M(m)$7.16M(m)-$4.81M
2017-12-31(m)(m)(m)(m)(m)(m)-$7.43M
2017-09-30(m)(m)$4.47M(m)$6.30M-$207.11K-$6.43M
2017-06-30(m)(m)$5.01M(m)$6.75M(m)-$7.08M
2017-03-31(m)(m)$5.99M(m)$7.67M(m)-$8.00M
2016-12-31(m)(m)(m)(m)(m)(m)-$7.33M
2016-09-30(m)(m)$5.57M(m)$7.21M(m)-$7.19M
2016-06-30(m)(m)$5.30M(m)$6.83M(m)-$6.81M
2016-03-31(m)(m)$4.53M(m)$5.88M(m)-$5.87M
2015-12-31(m)(m)(m)(m)(m)(m)-$3.36M
2015-09-30(m)(m)$1.52M(m)$2.02M(m)-$4.58M
2015-06-30(m)(m)$1.63M(m)$2.08M(m)-$2.13M
2015-03-31(m)(m)$1.42M(m)$1.93M(m)-$2.14M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$409.58M(m)$98.90M$393.13M(m)$128.00K-$115.86M
2025-06-30$271.50M(m)$94.33M$251.07M(m)-$960.00K-$107.39M
2024-06-30$162.16M(m)$86.68M$202.52M(m)$0.00-$147.70M
2023-06-30$141.28M(m)$38.37M$153.13M(m)$1.96M-$78.39M
2022-06-30$8.82M$0.00$28.38M$56.86M(m)$0.00-$81.07M
2021-06-30$0.00$0.00$31.10M$27.59M$58.69M$0.00-$61.54M
2020-06-30(m)(m)$38.06M(m)$50.27M$0.00-$50.81M
2019-06-30(m)(m)$18.61M(m)$23.87M(m)-$24.40M
2018-06-30(m)(m)$10.30M(m)$15.15M(m)-$13.09M
2017-06-30(m)(m)$10.99M(m)$14.42M(m)-$15.08M
2016-06-30(m)(m)$9.82M(m)$12.71M(m)-$12.68M
2015-06-30(m)(m)$3.04M(m)$4.02M(m)-$4.27M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$442.50M(m)$134.49M$401.30M(m)-$960.00K-$154.62M
2024-09-30$266.93M(m)$132.07M$298.09M(m)$0.00-$212.30M
2023-09-30$199.07M(m)$67.14M$236.31M(m)$1.28M-$140.59M
2022-09-30$25.67M$2.90M$43.25M$97.76M(m)$0.00-$125.89M
2021-09-30$0.00(m)$44.28M$47.82M$92.10M$0.00-$96.43M
2020-09-30(m)(m)$52.86M(m)$71.40M$0.00-$73.74M
2019-09-30(m)(m)$34.44M(m)$42.82M(m)-$43.54M
2018-09-30(m)(m)$16.34M(m)$23.40M-$217.42K-$21.37M
2017-09-30(m)(m)$15.46M(m)$20.72M-$207.11K-$21.51M
2016-09-30(m)(m)$15.39M(m)$19.92M(m)-$19.87M
2015-09-30(m)(m)$4.57M(m)$6.04M(m)-$8.85M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$638.50M(m)$183.28M$570.60M(m)-$530.00K-$183.17M
2024-12-31$385.69M(m)$187.08M$411.36M(m)$85.00K-$287.22M
2023-12-31$270.60M(m)$97.94M$323.12M(m)$960.00K-$239.24M
2022-12-31$50.04M$5.20M$57.95M$159.25M(m)$0.00-$187.13M
2021-12-31(m)(m)$58.06M$66.65M$124.71M$0.00-$130.40M
2020-12-31(m)(m)$70.24M$28.90M$99.14M$0.00-$102.90M
2019-12-31(m)(m)$53.65M(m)$67.25M$0.00-$68.35M
2018-12-31(m)(m)$23.50M(m)$32.85M$0.00-$30.97M
2017-12-31(m)(m)$19.96M(m)$27.16M$0.00-$28.94M
2016-12-31(m)(m)$21.20M(m)$27.54M$0.00-$27.20M
2015-12-31(m)(m)$6.78M(m)$9.20M(m)-$12.21M
2014-12-31(m)(m)$4.28M(m)$5.67M(m)-$6.00M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41